Therefore, we may find an apparent reduction in circulating fetuin-A levels if we perform similar experiments in diabetic model mice because hepatic PPARγ expression is elevated in rodent models of diabetes or obesity [27]. The gene discussed is PPARG; the disease is obesity disorder.